BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38762019)

  • 1. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism.
    Gabara C; Aibar J; Nishimoto Y; Yamashita Y; Prandoni P; Barnes GD; Bikdeli B; Jiménez D; Demelo-Rodríguez P; Peris ML; Nguyen ST; Monreal M;
    J Thromb Haemost; 2024 May; ():. PubMed ID: 38762019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism.
    Iñurrieta A; Pedrajas JM; Núñez MJ; López-Jiménez L; Velo-García A; García JC; Lecumberri R; Jiménez D; Pons I; Monreal M;
    TH Open; 2018 Oct; 2(4):e428-e436. PubMed ID: 31249971
    [No Abstract]   [Full Text] [Related]  

  • 4. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry.
    Lafaie L; Poenou G; Hanon O; López-Jiménez L; Nieto JA; Lorenzo A; Porras JA; Lumbierres M; Bertoletti L; Monreal M;
    J Am Geriatr Soc; 2024 Jan; 72(1):113-125. PubMed ID: 37814983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
    Newton DH; Monreal Bosch M; Amendola M; Wolfe L; Perez Ductor C; Lecumberri R; Levy MM;
    J Vasc Surg Venous Lymphat Disord; 2017 Jan; 5(1):18-24.e1. PubMed ID: 27987605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.
    Yamashita Y; Yoshikawa Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
    Int J Cardiol; 2019 Oct; 292():198-204. PubMed ID: 31239211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Presentation, Treatment, and Outcomes of Venous Thromboembolism in Long-Term Immobile Patients Based on Age.
    Weinberg I; Elgendy IY; Dicks AB; Marchena PJ; Malý R; Francisco I; Pedrajas JM; Font C; Hernández-Blasco L; Monreal M;
    J Gen Intern Med; 2023 Jun; 38(8):1877-1886. PubMed ID: 36750505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
    Bikdeli B; Caraballo C; Trujillo-Santos J; Galanaud JP; di Micco P; Rosa V; Cusidó GV; Schellong S; Mellado M; Del Valle Morales M; Gavín-Sebastián O; Mazzolai L; Krumholz HM; Monreal M;
    JAMA Cardiol; 2022 Aug; 7(8):857-865. PubMed ID: 35830171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons Between Upper and Lower Extremity Deep Vein Thrombosis: A Review of the RIETE Registry.
    Cote LP; Greenberg S; Caprini JA; Tafur A; Choi C; Muñoz FJ; Skride A; Valero B; Porras JA; Ciammaichella M; Hernández-Blasco LM; Monreal M;
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):748-754. PubMed ID: 27572888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.
    Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M;
    Eur J Intern Med; 2016 Jul; 32():53-9. PubMed ID: 26972931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
    Farge D; Trujillo-Santos J; Debourdeau P; Bura-Riviere A; Rodriguez-Beltrán EM; Nieto JA; Peris ML; Zeltser D; Mazzolai L; Hij A; Monreal M;
    Medicine (Baltimore); 2015 Aug; 94(32):e1235. PubMed ID: 26266353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet agents for the treatment of deep venous thrombosis.
    Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry.
    Bikdeli B; Jiménez D; Garcia-Tsao G; Barba R; Font C; Díaz-Pedroche MDC; Mazzolai L; Little DHW; Tufano A; Tafur AJ; Siegal D; Lip GYH; Monreal M;
    Semin Thromb Hemost; 2019 Nov; 45(8):793-801. PubMed ID: 31614388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
    Madridano O; del Toro J; Lorenzo A; Martín M; Gómez Cerezo J; Hernández L; Prandoni P; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2015 Apr; 3(2):135-41.e1. PubMed ID: 26993830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Prognosis of Nonmassive Central and Noncentral Pulmonary Embolism: A Registry-Based Cohort Study.
    Gouin B; Blondon M; Jiménez D; Fernández-Capitán C; Bounameaux H; Soler S; Duce R; Sahuquillo JC; Ruiz-Giménez N; Monreal M;
    Chest; 2017 Apr; 151(4):829-837. PubMed ID: 27876590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
    Blanco-Molina A; Enea I; Gadelha T; Tufano A; Bura-Riviere A; Di Micco P; Bounameaux H; González J; Villalta J; Monreal M;
    Medicine (Baltimore); 2014 Oct; 93(17):309-317. PubMed ID: 25398066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.